AAAAAA

   
Results: 1-11 |
Results: 11
CUTTING EDGE - TRANSCUTANEOUS IMMUNIZATION WITH CHOLERA-TOXIN PROTECTS MICE AGAINST LETHAL MUCOSAL TOXIN CHALLENGE
Authors: GLENN GM SCHARTONKERSTEN T VASSELL R MALLETT CP HALE TL ALVING C
Citation: Gm. Glenn et al., CUTTING EDGE - TRANSCUTANEOUS IMMUNIZATION WITH CHOLERA-TOXIN PROTECTS MICE AGAINST LETHAL MUCOSAL TOXIN CHALLENGE, The Journal of immunology (1950), 161(7), 1998, pp. 3211-3214
DOUBLE-BLIND VACCINE-CONTROLLED RANDOMIZED EFFICACY TRIAL OF AN INVESTIGATIONAL SHIGELLA-SONNEI CONJUGATE VACCINE IN YOUNG-ADULTS
Authors: COHEN D ASHKENAZI S GREEN MS GDALEVICH M ROBIN G SLEPON R YAVZORI M ORR N BLOCK C ASHKENAZI I SHEMER J TAYLOR DN HALE TL SADOFF JC PAVLIAKOVA D SCHNEERSON R ROBBINS JB
Citation: D. Cohen et al., DOUBLE-BLIND VACCINE-CONTROLLED RANDOMIZED EFFICACY TRIAL OF AN INVESTIGATIONAL SHIGELLA-SONNEI CONJUGATE VACCINE IN YOUNG-ADULTS, Lancet, 349(9046), 1997, pp. 155-159
SERUM ANTIBODY TO LIPOPOLYSACCHARIDE ANTIGENS OF SHIGELLA SPECIES AMONG US MILITARY PERSONNEL DEPLOYED TO SAUDI-ARABIA AND KUWAIT DURING OPERATIONS DESERT-SHIELD AND DESERT-STORM
Authors: HYAMS KC MALONE JD BOURGEOIS AL HAWKINS R HALE TL MURPHY JR
Citation: Kc. Hyams et al., SERUM ANTIBODY TO LIPOPOLYSACCHARIDE ANTIGENS OF SHIGELLA SPECIES AMONG US MILITARY PERSONNEL DEPLOYED TO SAUDI-ARABIA AND KUWAIT DURING OPERATIONS DESERT-SHIELD AND DESERT-STORM, Clinical and diagnostic laboratory immunology, 2(6), 1995, pp. 700-703
EVALUATION OF THE SAFETY, IMMUNOGENICITY, AND EFFICACY IN HEALTHY-ADULTS OF 4 DOSES OF LIVE ORAL HYBRID ESCHERICHIA-COLI SHIGELLA-FLEXNERI 2A VACCINE STRAIN ECSF2A-2
Authors: KOTLOFF KL LOSONSKY GA NATARO JP WASSERMAN SS HALE TL TAYLOR DN NEWLAND JW SADOFF JC FORMAL SB LEVINE MM
Citation: Kl. Kotloff et al., EVALUATION OF THE SAFETY, IMMUNOGENICITY, AND EFFICACY IN HEALTHY-ADULTS OF 4 DOSES OF LIVE ORAL HYBRID ESCHERICHIA-COLI SHIGELLA-FLEXNERI 2A VACCINE STRAIN ECSF2A-2, Vaccine, 13(5), 1995, pp. 495-502
A MODIFIED SHIGELLA VOLUNTEER CHALLENGE MODEL IN WHICH THE INOCULUM IS ADMINISTERED WITH BICARBONATE BUFFER - CLINICAL-EXPERIENCE AND IMPLICATIONS FOR SHIGELLA INFECTIVITY
Authors: KOTLOFF KL NATARO JP LOSONSKY GA WASSERMAN SS HALE TL TAYLOR DN SADOFF JC LEVINE MM
Citation: Kl. Kotloff et al., A MODIFIED SHIGELLA VOLUNTEER CHALLENGE MODEL IN WHICH THE INOCULUM IS ADMINISTERED WITH BICARBONATE BUFFER - CLINICAL-EXPERIENCE AND IMPLICATIONS FOR SHIGELLA INFECTIVITY, Vaccine, 13(16), 1995, pp. 1488-1494
PROTECTION AGAINST LOCAL SHIGELLA-SONNEI INFECTION IN MICE BY PARENTERAL IMMUNIZATION WITH A NUCLEOPROTEIN SUBCELLULAR VACCINE
Authors: LEVENSON VJ MALLETT CP HALE TL
Citation: Vj. Levenson et al., PROTECTION AGAINST LOCAL SHIGELLA-SONNEI INFECTION IN MICE BY PARENTERAL IMMUNIZATION WITH A NUCLEOPROTEIN SUBCELLULAR VACCINE, Infection and immunity, 63(7), 1995, pp. 2762-2765
INTRANASAL OR INTRAGASTRIC IMMUNIZATION WITH PROTEOSOME-SHIGELLA LIPOPOLYSACCHARIDE VACCINES PROTECTS AGAINST LETHAL PNEUMONIA IN A MURINE MODEL OF SHIGELLA INFECTION
Authors: MALLETT CP HALE TL KAMINSKI RW LARSEN T ORR N COHEN D LOWELL GH
Citation: Cp. Mallett et al., INTRANASAL OR INTRAGASTRIC IMMUNIZATION WITH PROTEOSOME-SHIGELLA LIPOPOLYSACCHARIDE VACCINES PROTECTS AGAINST LETHAL PNEUMONIA IN A MURINE MODEL OF SHIGELLA INFECTION, Infection and immunity, 63(6), 1995, pp. 2382-2386
ANTIBODY AND CYTOKINE RESPONSES IN A MOUSE PULMONARY MODEL OF SHIGELLA-FLEXNERI SEROTYPE 2A INFECTION
Authors: VANDEVERG LL MALLETT CP COLLINS HH LARSEN T HAMMACK C HALE TL
Citation: Ll. Vandeverg et al., ANTIBODY AND CYTOKINE RESPONSES IN A MOUSE PULMONARY MODEL OF SHIGELLA-FLEXNERI SEROTYPE 2A INFECTION, Infection and immunity, 63(5), 1995, pp. 1947-1954
PULMONARY ANTIBODY AND CYTOKINE PRODUCTION IN A MOUSE LUNG SHIGELLA INFECTION MODEL
Authors: VANDEVERG LL COLLINS HH MALLETT CP HALE TL
Citation: Ll. Vandeverg et al., PULMONARY ANTIBODY AND CYTOKINE PRODUCTION IN A MOUSE LUNG SHIGELLA INFECTION MODEL, Journal of cellular biochemistry, 1994, pp. 63-63
OUTPATIENT STUDIES OF THE SAFETY AND IMMUNOGENICITY OF AN AUXOTROPHICESCHERICHIA-COLI K-12 SHIGELLA-FLEXNERI 2A HYBRID VACCINE CANDIDATE, ECSF2A-2
Authors: TAYLOR DN PHILLIP DF ZAPOR M TROFA A VANDEVERG L HARTMAN A BENDIUK N NEWLAND JW FORMAL SB SADOFF JC HALE TL
Citation: Dn. Taylor et al., OUTPATIENT STUDIES OF THE SAFETY AND IMMUNOGENICITY OF AN AUXOTROPHICESCHERICHIA-COLI K-12 SHIGELLA-FLEXNERI 2A HYBRID VACCINE CANDIDATE, ECSF2A-2, Vaccine, 12(6), 1994, pp. 565-568
SAFETY AND IMMUNOGENICITY OF THE ORAL ESCHERICHIA-COLI K12 SHIGELLA-FLEXNERI 2A VACCINE (ECSF2A-2) AMONG ISRAELI SOLDIERS
Authors: COHEN D ASHKENAZI S GREEN MS YAVZORI M ORR N SLEPON R LERMAN Y ROBIN G AMBAR R BLOCK C TAYLOR DN HALE TL SADOFF JC WIENER M
Citation: D. Cohen et al., SAFETY AND IMMUNOGENICITY OF THE ORAL ESCHERICHIA-COLI K12 SHIGELLA-FLEXNERI 2A VACCINE (ECSF2A-2) AMONG ISRAELI SOLDIERS, Vaccine, 12(15), 1994, pp. 1436-1442
Risultati: 1-11 |